These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 33210338)

  • 21. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
    Das RR; Behera B; Mishra B; Naik SS
    Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
    Chen Y; Li MX; Lu GD; Shen HM; Zhou J
    Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients.
    Cassone A; Iacoviello L; Cauda R
    Future Microbiol; 2020 Oct; 15():1523-1526. PubMed ID: 33206554
    [No Abstract]   [Full Text] [Related]  

  • 25. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
    Lentini G; Cavalluzzi MM; Habtemariam S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
    Bilgin ZD; Evcil I; Yazgi D; Binay G; Okuyucu Genc C; Gulsen B; Huseynova A; Ozdemir AZ; Ozmen E; Usta Y; Ustun S; Caglar Andac S
    J Chromatogr Sci; 2021 Aug; 59(8):748-757. PubMed ID: 33336246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
    Réa-Neto Á; Bernardelli RS; Câmara BMD; Reese FB; Queiroga MVO; Oliveira MC
    Sci Rep; 2021 Apr; 11(1):9023. PubMed ID: 33907251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
    Junqueira DR; Rowe BH
    Br J Clin Pharmacol; 2021 Apr; 87(4):1758-1767. PubMed ID: 33047848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
    Ciorba A; Skarżyński PH; Pelucchi S; Hatzopoulos S
    J Glob Antimicrob Resist; 2020 Dec; 23():263-264. PubMed ID: 33075521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication.
    Weehuizen JM; Hoepelman AIM
    Eur J Clin Invest; 2020 Jul; 50(7):e13297. PubMed ID: 32474918
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
    Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
    Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
    Chen X; Geiger JD
    Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19.
    Gould S; Norris SL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):ED000151. PubMed ID: 33765340
    [No Abstract]   [Full Text] [Related]  

  • 39. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

  • 40. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.